Pfizer Inc (PFE) stock
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3046% above fair value
$29.45+0.09 (+0.31%)
Close on Nov 11, 2026Market cap $167.86BP/E 42.1Yield 5.84%
Pfizer statistics
102 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 2, 2027 (estimated, before the open)
- Last ex-dividend date
- Jul 24, 2026
- Fundamentals through
- Sep 27, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/OCF Ratio
- 11.59
- 12.93
Enterprise valuationIndustry
- EV / Sales
- 3.40
- 2.60
- EV / FCF
- 18.36
- 22.07
Share statisticsIndustry
- Shares Change (YoY)
- 0.31%
- 10.9%
- Float
- 5.70B
- 49M
- Shares Held by Insiders
- 0.03%
- 12.1%
- Shares Held by Institutions
- 67.2%
- 56.4%
Short sellingIndustry
- Short Interest
- 134M
- –
- Short Interest Change
- -2.46%
- -0.76%
- Short % of Float
- 2.36%
- 9.06%
- Short % of Shares Outstanding
- 2.36%
- 6.30%
- Days to Cover
- 4.58
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $31.44
- –
- 52-Week Low
- $23.62
- –
- 20-Day Moving Average
- $29.83
- –
- 50-Day Moving Average
- $28.80
- –
- 200-Day Moving Average
- $26.97
- –
- Average True Range (14)
- $0.74
- –
- Price Change (1 Week)
- -3.51%
- 1.51%
- Price Change (1 Month)
- -1.30%
- -2.37%
- Price Change (3 Months)
- 7.61%
- -21.1%
- Price Change (6 Months)
- 12.0%
- -22.8%
- Price Change (YTD)
- 15.8%
- -22.6%
- Price Change (1 Year)
- 13.0%
- -21.0%
- Price Change (3 Years)
- -0.52%
- -24.8%
- Price Change (5 Years)
- -42.0%
- -76.9%
- Price Change (10 Years)
- -11.5%
- -63.2%
- Average Volume (10 Days)
- 43M
- –
- Average Volume (20 Days)
- 36M
- –
- Average Volume (90 Days)
- 36M
- –
- Relative Volume
- 0.86
- 0.80
- Relative Strength Index (14)
- 44.3
- 44.7
- Volatility (1 Year)
- 21.7%
- 80.2%
- Beta (5 Years)
- 0.44
- 1.07
MarginsIndustry
- Pretax Margin
- 6.70%
- -11.8%
- EBITDA Margin
- 21.2%
- -27.7%
- FCF Margin
- 18.5%
- -8.85%
Returns on capitalIndustry
- Return on Equity (ROE)
- 4.44%
- -51.3%
- Return on Assets (ROA)
- 1.95%
- -40.7%
Financial positionIndustry
- Current Ratio
- 1.42
- 3.31
- Quick Ratio
- 0.79
- 2.41
- Debt / Equity
- 0.70
- 0.50
- Debt / EBITDA
- 4.65
- 3.15
- Debt / FCF
- 5.32
- 4.68
- Net Debt / EBITDA
- 3.84
- 1.97
GrowthIndustry
- Revenue Growth (YoY)
- 1.34%
- 7.26%
- Net Income Growth (YoY)
- -59.0%
- -14.4%
- EPS Growth (YoY)
- -59.3%
- -11.7%
- FCF Growth (YoY)
- 13.6%
- 7.48%
- Revenue Growth (3Y CAGR)
- -14.8%
- 2.25%
- Revenue Growth (5Y CAGR)
- 8.48%
- 6.41%
- EPS Growth (3Y CAGR)
- -37.1%
- -0.17%
- EPS Growth (5Y CAGR)
- -3.56%
- 3.77%
EfficiencyIndustry
- Asset Turnover
- 0.31
- 0.40
- Inventory Turnover
- 1.58
- 2.73
- Revenue Per Employee
- $848.33K
- $429.38K
- Profits Per Employee
- $53.77K
- -$683.67K
- Employee Count
- 75,000
- 75
- WACC
- 6.63%
- 10.0%
Income statement (TTM)Industry
- Pretax Income
- $4.26B
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- -$51.73B
- $16.98M
- Net Cash Per Share
- -$9.08
- $0.72
- Equity (Book Value)
- $89.00B
- $52.68M
- Book Value Per Share
- $15.62
- $1.50
- Tangible Book Value
- -$28.42B
- $26.74M
- Working Capital
- $13.28B
- $78.52M
Cash flow (TTM)Industry
- Capital Expenditures
- -$2.39B
- -$944.00K
- FCF Per Share
- $2.07
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 2.45%
- -21.0%
- FCF Yield
- 7.17%
- -9.44%
- Dividend Yield
- 5.97%
- 1.88%
- Shareholder Yield
- 5.97%
- 0.00%
- Dividend Per Share
- $1.72
- $0.83
- Dividend Growth (YoY)
- 1.78%
- 2.37%
- Years of Dividend Growth
- 15
- 0
Taxes and interestIndustry
- Interest Expense
- $2.71B
- $2.97M
- Income Tax
- $186.00M
- $74.00K
- Effective Tax Rate
- 4.37%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $15.68
- $19.34
- Graham Upside
- -45.6%
- -46.3%
- Altman Z-Score
- 2.03
- 0.26
- Piotroski F-Score
- 6
- 4
- Beneish M-Score
- -2.52
- -2.62
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | PFE | S&P 500 | Difference | PFE per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +4.1% | -2.4% | +6.5 pts | ||
| 3 months | +10.6% | -1.2% | +11.8 pts | ||
| Year to date | +24.4% | +12.3% | +12.1 pts | ||
| 1 year | +21.4% | +12.4% | +9.0 pts | ||
| 3 years | +19.5% | +78.8% | −59.3 pts | +6.1% | +21.4% |
| 5 years | -24.2% | +75.2% | −99.4 pts | -5.4% | +11.9% |
| 10 years | +48.5% | +311.1% | −262.6 pts | +4.0% | +15.2% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
134M PFE shares were sold short on Oct 30, 2026, down 2.5% from the previous report, or 2.36% of the shares available to trade. At recent volumes it would take 4.6 days to buy them back. Over the last 20 sessions, 39.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 134,422,620 | -2.5% | 29,322,354 | 4.6 |
| Oct 15, 2026 | 137,816,093 | -8.3% | 30,826,887 | 4.5 |
| Sep 30, 2026 | 150,217,617 | -3.2% | 34,031,762 | 4.4 |
| Sep 15, 2026 | 155,202,257 | +2.4% | 31,657,403 | 4.9 |
| Aug 31, 2026 | 151,537,890 | +1.5% | 35,022,905 | 4.3 |
| Aug 14, 2026 | 149,271,132 | -7.6% | 42,256,400 | 3.5 |
| Jul 31, 2026 | 161,478,227 | -1.4% | 38,594,371 | 4.2 |
| Jul 15, 2026 | 163,820,439 | +0.1% | 42,807,581 | 3.8 |
| Jun 30, 2026 | 163,578,117 | +0.9% | 60,914,282 | 2.7 |
| Jun 15, 2026 | 162,075,723 | -0.4% | 35,201,004 | 4.6 |
| May 29, 2026 | 162,659,281 | +3.3% | 32,807,683 | 5.0 |
| May 15, 2026 | 157,459,584 | +12.2% | 38,197,706 | 4.1 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?